A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Safety And Efficacy Of PF-04965842 In Subjects With Moderate To Severe Psoriasis

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Safety And Efficacy Of PF-04965842 In Subjects With Moderate To Severe Psoriasis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs PF 4965842 (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Oct 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 09 Sep 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top